Area of research
Pulmonary and Respiratory Medicine · Pathology and Forensic Medicine
Research interest
Research interests include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Systemic Sclerosis and Related Diseases, Inflammatory Myopathies and Dermatomyositis, and Neonatal Respiratory Health Research.
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement
Associations of interstitial lung disease subtype and CT pattern with lung function and survival
TMOD-12. Preclinical and clinical assessment of chemoradiation after mutant IDH inhibitor treatment in IDH-mutant glioma
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Epidemiologic Features of Recovery From SARS-CoV-2 Infection
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study
Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study
Modified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosis
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease
Abstract P540: Cardiovascular Disease Risk Factors and Antibody Response to COVID-19 Vaccination: The C4R Study
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease
Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
Methotrexate and rheumatoid arthritis associated interstitial lung disease
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures
Differences in Clinical Characteristics and Outcomes Between Men and Women With Idiopathic Pulmonary Fibrosis
A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis
Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature
Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease–Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
The Lung in Rheumatoid Arthritis
Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis